8-143429934-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_201589.4(MAFA):c.473C>A(p.Ala158Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000238 in 1,258,850 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_201589.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAFA | NM_201589.4 | c.473C>A | p.Ala158Glu | missense_variant | 1/1 | ENST00000333480.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAFA | ENST00000333480.3 | c.473C>A | p.Ala158Glu | missense_variant | 1/1 | NM_201589.4 | P1 | ||
MAFA | ENST00000528185.1 | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes ? AF: 0.000122 AC: 18AN: 147476Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000936 AC: 1AN: 10682Hom.: 0 AF XY: 0.000140 AC XY: 1AN XY: 7164
GnomAD4 exome AF: 0.0000108 AC: 12AN: 1111270Hom.: 0 Cov.: 34 AF XY: 0.00000935 AC XY: 5AN XY: 534778
GnomAD4 genome ? AF: 0.000122 AC: 18AN: 147580Hom.: 0 Cov.: 30 AF XY: 0.0000973 AC XY: 7AN XY: 71922
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.473C>A (p.A158E) alteration is located in exon 1 (coding exon 1) of the MAFA gene. This alteration results from a C to A substitution at nucleotide position 473, causing the alanine (A) at amino acid position 158 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at